Caerus Discovery Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $50K
Latest Deal Amount
  • Investors
  • 1

Caerus Discovery General Information


Developer of therapeutic products intended to counter zika virus. The company develops antibody and therapeutic products for treatment of human diseases, including infectious, inflammatory, metabolic, neurological, malignant diseases and zika using immune synapse and subtractive immunization providing patients with therapeutic products to counter zika virus.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 10900 University Boulevard
  • Manassas, VA 20110
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Caerus Discovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 15-Feb-2017 $50K Completed Startup
To view Caerus Discovery’s complete valuation and funding history, request access »

Caerus Discovery Executive Team (2)

Name Title Board Seat Contact Info
Cohava Gelber Ph.D Co-Founder, Chief Executive Officer & President
Soren Mogelsvang Ph.D Co-Founder
To view Caerus Discovery’s complete executive team members history, request access »

Caerus Discovery Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Prince William County Corporation 000 0000 000000 0
To view Caerus Discovery’s complete investors history, request access »